Advisor Group Holdings, Inc. Moleculin Biotech, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.85 - $16.65 $2,662 - $52,147	-3,132 Reduced 76.39%	968 $1,000
Q3 2022 Nov 14, 2022	BUY	$1.15 - $17.4 $170 - $2,575	148 Added 3.74%	4,100 $4,000
Q2 2022 Aug 10, 2022	SELL	$1.19 - $2.0 $334 - $562	-281 Reduced 6.64%	3,952 $6,000
Q1 2022 May 04, 2022	BUY	$1.23 - $1.9 $4,221 - $6,520	3,432 Added 428.46%	4,233 $7,000
Q1 2021 May 13, 2021	BUY	$3.7 - $6.42 $2,963 - $5,142	801 New	801 $3,000

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $48.6M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.